Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$984M |
| 2 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$406M |
| 3 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$363M |
| 4 |
Comcast
CMCSA
|
+$305M |
| 5 |
DuPont de Nemours
DD
|
+$229M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.98B |
| 2 |
Linde
LIN
|
+$1.14B |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$976M |
| 4 |
AGN
Allergan plc
AGN
|
+$735M |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$469M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.7% |
| 2 | Financials | 4.92% |
| 3 | Consumer Discretionary | 4.46% |
| 4 | Healthcare | 4.33% |
| 5 | Communication Services | 4.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CHUY
3876
DELISTED
Chuy's Holdings, Inc. Common Stock
CHUY
| $239K | ﹤0.01% |
16,037
+2,290
| +17% | +$34.3K |
|
|
VEDL
3877
DELISTED
Vedanta Limited American Depostary Shares (Each representing four equity shares)
VEDL
| $239K | ﹤0.01% |
42,500
-6,281
| -13% | -$29.7K |
|
|
VST.WS.A
3878
DELISTED
Vistra Corp.Warrants to purchase Common Stock (Expiring February 2, 2024)
VST.WS.A
| $238K | ﹤0.01% |
12,758
| – | – |
|
3879
CALL
Hecla Mining
HL
$10.7B
| $237K | ﹤0.01% |
72,600
-110,100
| -60% | -$304K |
|
|
IMDX
3880
Insight Molecular Diagnostics
IMDX
$155M
| $237K | ﹤0.01% |
6,192
-2,681
| -30% | -$138K |
|
|
REVG
3881
DELISTED
REV Group
REVG
| $237K | ﹤0.01% |
38,666
+17,859
| +86% | +$95.8K |
|
3882
iShares National Muni Bond ETF
MUB
$45.3B
| $236K | ﹤0.01% |
+2,045
| New | +$232K |
|
3883
Novartis
NVS
$293B
| $236K | ﹤0.01% |
2,696
-42,122
| -94% | -$3.64M |
|
3884
United States Natural Gas Fund
UNG
$450M
| $236K | ﹤0.01% |
5,741
-69,906
| -92% | -$3.33M |
|
|
TGP
3885
DELISTED
Teekay LNG Partners L.P.
TGP
| $236K | ﹤0.01% |
+20,242
| New | +$229K |
|
|
RST
3886
DELISTED
ROSETTA STONE INC
RST
| $236K | ﹤0.01% |
14,053
+7,172
| +104% | +$121K |
|
3887
PUT
Alcoa
AA
$12.5B
| $235K | ﹤0.01% |
20,900
-31,200
| -60% | -$279K |
|
3888
CALL
Toll Brothers
TOL
$14.1B
| $235K | ﹤0.01% |
7,200
-39,800
| -85% | -$1.09M |
|
|
CNR
3889
Core Natural Resources Inc
CNR
$4.47B
| $235K | ﹤0.01% |
46,670
+36,159
| +344% | +$225K |
|
3890
PUT
Ambarella
AMBA
$3.68B
| $234K | ﹤0.01% |
5,100
-26,200
| -84% | -$1.35M |
|
3891
PUT
Kroger
KR
$35.1B
| $234K | ﹤0.01% |
6,900
-64,600
| -90% | -$2.1M |
|
3892
CALL
Rockwell Automation
ROK
$49.1B
| $234K | ﹤0.01% |
1,100
-5,300
| -83% | -$1.03M |
|
|
3893
PUT
Linde
LIN
$226B
| $233K | ﹤0.01% |
1,100
-21,100
| -95% | -$4.07M |
|
3894
MKS Inc
MKSI
$19.7B
| $233K | ﹤0.01% |
2,061
-19,443
| -90% | -$1.93M |
|
|
AUY
3895
PUT
DELISTED
Yamana Gold, Inc.
AUY
| $233K | ﹤0.01% |
42,600
-171,500
| -80% | -$820K |
|
3896
Dime Commercial Bancshares
DCOM
$1.81B
| $232K | ﹤0.01% |
10,141
+4,722
| +87% | +$97K |
|
3897
PUT
Penske Automotive Group
PAG
$14.2B
| $232K | ﹤0.01% |
6,000
-6,000
| -50% | -$209K |
|
3898
PUT
Enterprise Products Partners
EPD
$82.3B
| $231K | ﹤0.01% |
12,700
-1,215,500
| -99% | -$21.7M |
|
|
PINC
3899
DELISTED
Premier
PINC
| $231K | ﹤0.01% |
6,744
-68,314
| -91% | -$2.24M |
|
3900
Ribbon Communications
RBBN
$376M
| $231K | ﹤0.01% |
58,595
+24,635
| +73% | +$89.5K |
|
Similar funds
Barclays's Q2 2020 Portfolio in Review
As of Q2 2020, Barclays held 6,627 positions worth $129B, up 2.3% from $127B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Barclays withdrew a net $22.7B in Q2 2020, closing 960 positions and reducing 2,655 holdings. Its most notable exit was Allergan plc, an estimated $735M position sold in full.
By sector, the portfolio is most concentrated in Technology at 9.7% of assets, up from 8.3% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Barclays opened a new position in iShares MSCI ACWI ex US ETF worth $123M.
- Barclays's largest Q2 2020 buy was iShares MSCI ACWI ex US ETF: 2,853,067 shares worth $123M.
- Barclays added most to iShares iBoxx $ High Yield Corporate Bond ETF in Q2 2020, an estimated $984M increase.
- Barclays's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.98B.
- Barclays fully exited Allergan plc in Q2 2020, selling an estimated $735M.
- Barclays's ten largest holdings make up 34% of its $129B portfolio in Q2 2020.
- Barclays opened 468 new positions and closed 960 in Q2 2020.
- Barclays's portfolio value rose 2.3% quarter-over-quarter to $129B.
Based on Barclays's 13F filing for Q2 2020, filed 12 Aug 2020.